-
1
-
-
79955493066
-
-
eds. Harrison's, 16th ed
-
Dennis L. Kasper, Eugene Braunwald, Anthony S. Fauci, et al. eds. Harrison's Principles of internal medicine 16th ed 2005;.226:1434-1436.
-
(2005)
Principles of Internal Medicine
, vol.226
, pp. 1434-1436
-
-
Kasper, D.L.1
Braunwald, E.2
Anthony, S.3
Fauci, F.4
-
2
-
-
0003575082
-
Cardiovascular Survey Methods
-
2nd Edition, Geneva, World Health Organization
-
Rose GA, Blackburn H, Gillum RF, Princes RJ. Cardiovascular Survey Methods, 2nd Edition, Monograph Series No. 56, Geneva, World Health Organization 1982; 173-175.
-
(1982)
Monograph Series No. 56
, pp. 173-175
-
-
Rose, G.A.1
Blackburn, H.2
Gillum, R.F.3
Princes, R.J.4
-
5
-
-
0037125872
-
Smoking status and risk for recurrent coronary events after myocardial infarction
-
Thomas D. Rea, Heckbert, Kaplan Smith, Lemaitre, and Psaty. Smoking status and risk for recurrent coronary events after myocardial infarction. Ann Intern Med 2002; 137(6): 494-500.
-
(2002)
Ann Intern Med
, vol.137
, Issue.6
, pp. 494-500
-
-
Thomas, D.1
Rea, H.2
Kaplan, S.3
Lemaitre4
Psaty5
-
6
-
-
24644445134
-
Effect of cigarette smoking on survival of patients with angiographically documented coronary artery disease
-
Frye, Thomas Killip III
-
Ronald E. Vlietstra, Richard A. Kronmal, Albert Oberman, Robert L. Frye, Thomas Killip III. Effect of cigarette smoking on survival of patients with angiographically documented coronary artery disease. JAMA. 1986; 255(8):1023-1027.
-
(1986)
JAMA
, vol.255
, Issue.8
, pp. 1023-1027
-
-
Vlietstra, R.E.1
Kronmal, R.A.2
Albert Oberman, R.L.3
-
7
-
-
0016437103
-
Cigarette smoking and arteriographically demonstrable coronary artery disease
-
Walter H. Herbert.Cigarette smoking and arteriographically demonstrable coronary artery disease. Chest 1975; 67:49-52.
-
(1975)
Chest
, vol.67
, pp. 49-52
-
-
Herbert, W.H.1
-
8
-
-
0030048029
-
A smoking dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene
-
Xing L. Wang, Ah Siew Sim, Renee F. Badenhop, et al. A smoking dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nature Medicine 1996; 2: 41-45.
-
(1996)
Nature Medicine
, vol.2
, pp. 41-45
-
-
Wang, X.L.1
Siew Sim, A.2
Badenhop, R.F.3
-
9
-
-
0021943771
-
Smoking and coronary artery disease assessed by routine coronary arteriography
-
Ramsdale DR, E B Faragher, C L Bray, D H Bennett, C Ward, and D C Beton. Smoking and coronary artery disease assessed by routine coronary arteriography. Br Med J (Clin Res Ed) 1985; 290(6463): 197-200.
-
(1985)
Br Med J (Clin Res Ed)
, vol.290
, Issue.6463
, pp. 197-200
-
-
Ramsdale, D.R.1
Faragher, E.B.2
Bray, C.L.3
Bennett, D.H.4
Ward, C.5
Beton, D.C.6
-
10
-
-
0036706191
-
The association between inflammation markers, coronary artery disease and smoking
-
Moniek P. M. de Maat, Cornelis Kluft. The association between inflammation markers, coronary artery disease and smoking. Vascular Pharmacology 2002: 39(3): 137-139.
-
(2002)
Vascular Pharmacology
, vol.39
, Issue.3
, pp. 137-139
-
-
de Maat, M.P.M.1
Kluft, C.2
-
11
-
-
0023734634
-
Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry
-
Hermanson B, GS Omenn, RA Kronmal, and BJ Gersh. Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry. NEJM 1988; 319(21):1365-1369.
-
(1988)
NEJM
, vol.319
, Issue.21
, pp. 1365-1369
-
-
Hermanson, B.1
Omenn, G.S.2
Kronmal, R.A.3
Gersh, B.J.4
-
12
-
-
67650716511
-
Smoking cessation initiated during hospital stay for patients with coronary artery disease: A randomized controlled trial
-
Patricia M. Smith and Ellen Burgess. Smoking cessation initiated during hospital stay for patients with coronary artery disease: a randomized controlled trial. CMAJ 2009; 180 (13):8-15.
-
(2009)
CMAJ
, vol.180
, Issue.13
, pp. 8-15
-
-
Smith, P.M.1
Burgess, E.2
-
13
-
-
0032785013
-
Impact of smoking cessation and smoking interventions in patients with coronary heart disease
-
Van Berkel T.F.M., H. Boersma, J.W. Roos-Hesselink, R.A.M. Erdman and M.L. Simoons. Impact of smoking cessation and smoking interventions in patients with coronary heart disease. European Heart Journal 1999; 20(24):1773-1782.
-
(1999)
European Heart Journal
, vol.20
, Issue.24
, pp. 1773-1782
-
-
Van Berkel, T.F.M.1
Boersma, H.2
Roos-Hesselink, J.W.3
Erdman, R.A.M.4
Simoons, M.L.5
-
14
-
-
0030670828
-
Factors influencing smoking cessation in patients with coronary artery disease
-
McKenna, Kryss; Higgins, Helen. Factors influencing smoking cessation in patients with coronary artery disease. Patient education and counseling 1997; 32(3):197-205.
-
(1997)
Patient Education and Counseling
, vol.32
, Issue.3
, pp. 197-205
-
-
McKenna, K.1
Higgins, H.2
-
15
-
-
0000703842
-
The diagnosis of ischemic heart pain and intermittent claudication in field surveys
-
Rose GA. The diagnosis of ischemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962; 27:645-658.
-
(1962)
Bull World Health Organ
, vol.27
, pp. 645-658
-
-
Rose, G.A.1
-
16
-
-
43049161387
-
Prevalence of angina, myocardial infarction and intermittent claudication assessed by Rose Questionnaire among patients with Behcet's syndrome
-
Ugurlu S, E. Seyahi and Yazici H. Prevalence of angina, myocardial infarction and intermittent claudication assessed by Rose Questionnaire among patients with Behcet's syndrome. Rheumatology 2008; 47(4):472-475.
-
(2008)
Rheumatology
, vol.47
, Issue.4
, pp. 472-475
-
-
Ugurlu, S.1
Seyahi, E.2
Yazici, H.3
-
17
-
-
0025676651
-
Intermittent claudication, heart disease risk factors, and mortality
-
Smith GD, Shipley MJ and Rose G. Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. Circulation 2000; 82: 1925-1931.
-
(2000)
The Whitehall Study. Circulation
, vol.82
, pp. 1925-1931
-
-
Smith, G.D.1
Shipley, M.J.2
Rose, G.3
-
18
-
-
0003536740
-
-
U.S. Preventive Services Task Force, 2nd ed. Washington, DC: Office of Disease Prevention and Health Promotion
-
U.S. Preventive Services Task Force. Guide to Clinical Preventive Services, 2nd ed. Washington, DC: Office of Disease Prevention and Health Promotion; 1996;776-990
-
(1996)
Guide to Clinical Preventive Services
, pp. 776-990
-
-
|